LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR)

CUSIP: 514766104

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Common Stock
Shares outstanding
37,253,000
Total 13F shares
25,537,059
Share change
+1,393,340
Total reported value
$235,449,630
Price per share
$9.22
Number of holders
91
Value change
+$11,336,792
Number of buys
39
Number of sells
50

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 514766104?
CUSIP 514766104 identifies LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
WYNNEFIELD CAPITAL INC
13F
Company
8.4%
3,145,887
$35,391,000 30 Jun 2021
13F
Legion Partners Asset Management, LLC
13F
Company
7.9%
2,928,090
$32,941,000 30 Jun 2021
13F
BlackRock Finance, Inc.
13F
Company
5.9%
2,205,409
$24,810,000 30 Jun 2021
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
5.6%
2,069,993
$23,287,000 30 Jun 2021
13F
Cove Street Capital, LLC
13F
Company
4.8%
1,792,544
$20,166,000 30 Jun 2021
13F
VANGUARD GROUP INC
13F
Company
3.8%
1,397,995
$15,728,000 30 Jun 2021
13F
INVESTMENT COUNSELORS OF MARYLAND LLC
13F
Company
3.3%
1,237,620
$13,923,000 30 Jun 2021
13F
HEARTLAND ADVISORS INC
13F
Company
3.3%
1,231,315
$13,852,000 30 Jun 2021
13F
KENNEDY CAPITAL MANAGEMENT LLC
13F
Company
2.4%
884,803
$9,954,000 30 Jun 2021
13F
Russell Investments Group, Ltd.
13F
Company
2%
754,928
$8,491,000 30 Jun 2021
13F
Pacific Ridge Capital Partners, LLC
13F
Company
1.5%
571,686
$6,431,000 30 Jun 2021
13F
22NW, LP
13F
Company
1.5%
550,259
$6,190,000 30 Jun 2021
13F
STATE STREET CORP
13F
Company
1.4%
531,633
$5,981,000 30 Jun 2021
13F
Visionary Wealth Advisors
13F
Company
1.3%
494,425
$5,562,000 30 Jun 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.2%
451,082
$5,074,000 30 Jun 2021
13F
Walthausen & Co., LLC
13F
Company
1%
387,467
$4,359,000 30 Jun 2021
13F
NORTHERN TRUST CORP
13F
Company
0.73%
271,973
$3,060,000 30 Jun 2021
13F
J. Goldman & Co LP
13F
Company
0.72%
268,450
$3,020,000 30 Jun 2021
13F
FULLER & THALER ASSET MANAGEMENT, INC.
13F
Company
0.68%
253,995
$2,857,000 30 Jun 2021
13F
TOCQUEVILLE ASSET MANAGEMENT L.P.
13F
Company
0.67%
250,100
$2,814,000 30 Jun 2021
13F
Bank of New York Mellon Corp
13F
Company
0.64%
239,514
$2,695,000 30 Jun 2021
13F
Acuitas Investments, LLC
13F
Company
0.58%
217,717
$2,449,000 30 Jun 2021
13F
IQ EQ FUND MANAGEMENT (IRELAND) Ltd
13F
Company
0.58%
216,828
$2,439,000 30 Jun 2021
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.54%
200,651
$2,257,000 30 Jun 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.48%
177,895
$2,002,000 30 Jun 2021
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
0.47%
174,461
$1,963,000 30 Jun 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.45%
168,979
$1,901,000 30 Jun 2021
13F
SG Capital Management LLC
13F
Company
0.39%
144,613
$1,627,000 30 Jun 2021
13F
Boston Partners
13F
Company
0.34%
127,760
$1,438,000 30 Jun 2021
13F
D. E. Shaw & Co., Inc.
13F
Company
0.27%
101,332
$1,140,000 30 Jun 2021
13F
JPMORGAN CHASE & CO
13F
Company
0.27%
100,246
$1,128,000 30 Jun 2021
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.27%
99,315
$1,117,000 30 Jun 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.25%
92,729
$1,043,000 30 Jun 2021
13F
ROYAL BANK OF CANADA
13F
Company
0.24%
91,102
$1,025,000 30 Jun 2021
13F
CHARTWELL INVESTMENT PARTNERS, LLC
13F
Company
0.22%
82,793
$931,000 30 Jun 2021
13F
Ancora Advisors LLC
13F
Company
0.21%
79,089
$890,000 30 Jun 2021
13F
ROYCE & ASSOCIATES LP
13F
Company
0.2%
75,610
$851,000 30 Jun 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.2%
72,878
$820,000 30 Jun 2021
13F
Swiss National Bank
13F
Company
0.17%
64,600
$727,000 30 Jun 2021
13F
PERRITT CAPITAL MANAGEMENT INC
13F
Company
0.17%
63,100
$710,000 30 Jun 2021
13F
Invesco Ltd.
13F
Company
0.16%
60,776
$684,000 30 Jun 2021
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.15%
56,531
$636,000 30 Jun 2021
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.14%
53,283
$599,000 30 Jun 2021
13F
OPPENHEIMER ASSET MANAGEMENT INC.
13F
Company
0.14%
50,381
$567,000 30 Jun 2021
13F
CITADEL ADVISORS LLC
13F
Company
0.13%
50,102
$564,000 30 Jun 2021
13F
GAMCO INVESTORS, INC. ET AL
13F
Company
0.12%
46,500
$523,000 30 Jun 2021
13F
Squarepoint Ops LLC
13F
Company
0.11%
41,193
$463,000 30 Jun 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.11%
40,670
$458,000 30 Jun 2021
13F
Defender Capital, LLC.
13F
Company
0.11%
40,000
$450,000 30 Jun 2021
13F
GABELLI FUNDS LLC
13F
Company
0.1%
39,000
$439,000 30 Jun 2021
13F

Institutional Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q3 2021

As of 30 Sep 2021, LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) was held by 91 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 25,537,059 shares. The largest 10 holders included WYNNEFIELD CAPITAL INC, Legion Partners Asset Management, LLC, BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, Cove Street Capital, LLC, ISZO CAPITAL MANAGEMENT LP, VANGUARD GROUP INC, HEARTLAND ADVISORS INC, 22NW, LP, and KENNEDY CAPITAL MANAGEMENT, INC.. This page lists 91 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
95
Q3 2021 holders
91
Holder diff
-4
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 Value $ Q3 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.